Literature DB >> 20548296

Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition.

B Morar1, M Dragović, F A V Waters, D Chandler, L Kalaydjieva, A Jablensky.   

Abstract

Linkage of 10q22-q23 to schizophrenia and the recently reported association of Neuregulin 3 (NRG3) polymorphisms with high 'delusion factor' scores led us to attempt replication and further refinement of these findings in a sample of 411 schizophrenic patients and 223 nonpsychiatric control subjects. Using quantitative cognitive traits, patients were grouped into a cluster with pervasive cognitive deficit (CD) and a cluster with relatively spared cognition (CS). We found a significant association between rs6584400 and schizophrenia, with a trend for rs10883866. Post hoc analysis revealed that this result was mainly due to the CS cluster, characterized by elevated scores on Schneiderian first-rank symptoms, salience of complex delusions and positive thought disorder--thus closely related to the 'delusion factor'. In addition, both rs6584400 and rs10883866 were associated with the degraded-stimulus continuous performance task in which 'risk' alleles were associated with better than average performance in patients and worse performance in controls. This suggests that NRG3 may be modulating early attentional processes for perceptual sensitivity and vigilance, with opposite effects in affected individuals and healthy controls. The two single-nucleotide polymorphisms are in close proximity to the alternative first exons of the NRG3-a, -b and -d isoforms, of which the human brain-specific NRG-b appears to be the most interesting candidate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20548296     DOI: 10.1038/mp.2010.70

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  32 in total

1.  Associations between TCF4 gene polymorphism and cognitive functions in schizophrenia patients and healthy controls.

Authors:  Xianghua Zhu; Huang Gu; Zhen Liu; Zhansheng Xu; Xiongying Chen; Xiaochen Sun; Jinguo Zhai; Qiumei Zhang; Min Chen; Keqin Wang; Xiaoxiang Deng; Feng Ji; Chuanxin Liu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2012-11-09       Impact factor: 7.853

Review 2.  Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders.

Authors:  Miranda L Fisher; Anu Loukola; Jaakko Kaprio; Jill R Turner
Journal:  Int Rev Neurobiol       Date:  2015-09-16       Impact factor: 3.230

3.  Category fluency, latent semantic analysis and schizophrenia: a candidate gene approach.

Authors:  Kristin K Nicodemus; Brita Elvevåg; Peter W Foltz; Mark Rosenstein; Catherine Diaz-Asper; Daniel R Weinberger
Journal:  Cortex       Date:  2013-12-20       Impact factor: 4.027

Review 4.  Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Authors:  Xiangyou Hu; Qingyuan Fan; Hailong Hou; Riqiang Yan
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

5.  Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.

Authors:  Clare Paterson; Yanhong Wang; Thomas M Hyde; Daniel R Weinberger; Joel E Kleinman; Amanda J Law
Journal:  Am J Psychiatry       Date:  2016-10-24       Impact factor: 18.112

Review 6.  Genetic insights into the functional elements of language.

Authors:  Adam Szalontai; Katalin Csiszar
Journal:  Hum Genet       Date:  2013-06-08       Impact factor: 4.132

Review 7.  Neuregulin 3 and its roles in schizophrenia risk and presentation.

Authors:  Dimitrios Avramopoulos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-29       Impact factor: 3.568

8.  Effects of neuregulin 3 genotype on human prefrontal cortex physiology.

Authors:  Heike Tost; Joseph H Callicott; Roberta Rasetti; Radhakrishna Vakkalanka; Venkata S Mattay; Daniel R Weinberger; Amanda J Law
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

Review 9.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

10.  Neuregulin 3 Knockout Mice Exhibit Behaviors Consistent with Psychotic Disorders.

Authors:  Lindsay N Hayes; Alexey Shevelkin; Mariela Zeledon; Gary Steel; Pei-Lung Chen; Cassandra Obie; Ann Pulver; Dimitrios Avramopoulos; David Valle; Akira Sawa; Mikhail V Pletnikov
Journal:  Mol Neuropsychiatry       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.